Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Clinical trial NCT03447769 · TERMINATED
Trial details
- NCT number
- NCT03447769
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2022-03-17
- Enrollment
- 1382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.